Hepatitis B Reagents
ViroStat, Portland, Me, has expanded its offering of hepatitis B reagents, including its Monotope and Omnitope antibodies and recombinant antigens.
Read MorePosted by Jenny Lower | Dec 1, 2014 | Biochemicals & Chemical Reagents, Infectious Diseases |
ViroStat, Portland, Me, has expanded its offering of hepatitis B reagents, including its Monotope and Omnitope antibodies and recombinant antigens.
Read MorePosted by Jenny Lower | Nov 24, 2014 | Emerging & Zoonotic Diseases, Infectious Diseases, POC Reagents & Test Kits, Point-of-Care |
The portable Firefly Dx system from PositiveID Corp can quickly detect pathogens such as ebola and E. coli in patients and in the environment, leading to more rapid and effective treatment.
Read MorePosted by Steve Halasey | Nov 4, 2014 | Uncategorized |
Selling its US health services unit will enable Alere to sharpen its focus on enhancing leadership in the global rapid diagnostics market.
Read MorePosted by Jenny Lower | Oct 31, 2014 | Diabetes & Metabolic Diseases, Heart Disease, Kidney Disease |
With the prevalence of diabetes continuing on an upward trajectory both in the United States and overseas, healthcare professionals are continuing to search for more effective methods of preventing, detecting, and treating the disease.
Read MorePosted by Steve Halasey | Oct 27, 2014 | Emerging & Zoonotic Diseases, Infectious Diseases, Molecular Diagnostics |
Under an FDA emergency use authorization, BioFire’s commercial BioThreat-E test for the ebola Zaire virus is now available to high- and moderate-complexity clinical laboratories in the United States.
Read More